Long-term viable chimeric nephrons generated from progenitor cells are a reliable model in cisplatin-induced toxicity

Kenji Matsui1, Shuichiro Yamanaka2, Sandy Chen1

  • 1Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, 105-8461, Japan.

Communications Biology
|October 29, 2023
PubMed

Insights

Neonatal injection of renal progenitor cells generates chimeric nephrons integrated with host urinary tracts, enabling long-term viability and function. This method offers a promising approach for kidney regeneration and drug screening.

Area of Science:

  • Regenerative Medicine
  • Developmental Biology
  • Nephrology

Background:

  • Kidney organoids show limited in vitro maturity and lack urinary tract integration for long-term viability.
  • Previous transplantation methods into adult mice have not achieved long-term viable generated nephrons due to lack of integration.
  • Demonstrating long-term viable, functional nephrons is crucial for advancing kidney research and therapies.

Purpose of the Study:

  • To develop an approachable method for generating long-term viable, functional nephrons in vivo.
  • To investigate the integration and maturation of xenografted renal progenitor cells within a host kidney.
  • To establish a model for studying kidney injury and regeneration.

Main Methods:

  • Injection of mouse and rat renal progenitor cells into neonatal mouse kidneys.
  • Generation of chimeric nephrons with integration into the host urinary tract.
  • Assessment of nephron maturation, viability, function (excretion/reabsorption), and response to cisplatin-induced injury using single-cell RNA-sequencing.

Main Results:

  • Successfully generated chimeric nephrons integrated with host urinary tracts.
  • Chimeric nephrons demonstrated similar maturation to host nephrons and long-term viability.
  • Functional excretion and reabsorption capabilities were observed, along with responses to acute and chronic cisplatin injury.
  • Human nephron progenitor cells also differentiated into nephrons within neonatal kidneys.

Conclusions:

  • Neonatal injection of renal progenitor cells is a promising approach for in vivo nephron generation.
  • This method facilitates long-term viability and functional integration of generated nephrons.
  • Potential applications include kidney regeneration, drug screening, and pathological analysis.

Related Concept Videos

Reproductive Cloning01:27

Reproductive Cloning

Reproductive cloning is the process of producing a genetically identical copy—a clone—of an entire organism. While clones can be produced by splitting an early embryo—similar to what happens naturally with identical twins—cloning of adult animals is usually done by a process called somatic cell nuclear transfer (SCNT).
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic cell—any cell that is not a sex...
Cell Lines01:16

Cell Lines

A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...